1-3 of 3
Alessandra Rossi
Close
Sort by
Journal Articles

Targeted DNA Damage Boost with Loncastuximab Tesirine in Combination with PARP Inhibitors in Diffuse Large B-Cell Lymphoma

Stefania Fusani, Alessandra Rossi, Saveria Mazzara, Elena Baiardi, Stefania Orecchioni, Giovanna Talarico, Paolo Falvo, Francesca Zammarchi, Patrick Van Berkel, Stefano A. Pileri, Francesco Bertolini, Corrado Tarella, Enrico Derenzini
Journal: Blood
Blood (2023) 142 (Supplement 1): 5780.
https://doi.org/10.1182/blood-2023-188475
Published: 2023
Journal Articles

CD19-Mediated DNA Damage Boost in Lymphoma Cells Treated with Loncastuximab Tesirine in Combination with PARP Inhibitors

Stefania Fusani, Alessandra Rossi, Saveria Mazzara, Elena Baiardi, Francesca Zammarchi, Patrick H van Berkel, Stefano A Pileri, Corrado Tarella, Enrico Derenzini
Journal: Blood
Blood (2021) 138 (Supplement 1): 1342.
https://doi.org/10.1182/blood-2021-150464
Published: 2021
Journal Articles

Integration of Nanostring Profiling and Functional Characterization of Oxidative and Replicative Stress Biomarkers Identifies Poor Prognosis MYC/BCL-2 Positive Diffuse Large B-Cell Lymphoma Subsets, Providing Opportunities for Precision Therapies

Enrico Derenzini, MD PhD, Alessandra Rossi, PhD, Claudio Agostinelli, MD, Maura Rossi, PhD, Federica Melle, PhD, Giovanna Motta, PhD, Marco Fabbri, PhD, Tommaso Radice, MD, Safaa Ramadan, PhD MD, Anna Vanazzi, MD, Valentina Tabanelli, MD, Stefano Fiori, MD, Annalisa Chiappella, MD, Alberto Agazzi, MD, Pier Luigi Zinzani, MD, Umberto Vitolo, Corrado Tarella, MD Prof, Stefano A. Pileri, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 676.
https://doi.org/10.1182/blood-2018-99-118329
Published: 2018